Nerio Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1.3B

Nerio Therapeutics General Information

Description

Operator of a biopharmaceutical company intended to empower phosphatase drug discovery for immunotherapy. The company offers novel phosphatase modulators, leveraging deep expertise in protein phosphatases, high-throughput screening technologies and structure-guided chemistry approaches, enabling therapeutic intervention with selective, cell-permeable, bioavailable and efficacious small molecule phosphatase modulators for immuno-oncology applications.

Contact Information

Website
www.neriotx.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 11099 North Torrey Pines Road
  • Suite 280
  • La Jolla, CA 92037
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Boehringer Ingelheim
Corporate Office
  • 11099 North Torrey Pines Road
  • Suite 280
  • La Jolla, CA 92037
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nerio Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 29-Jul-2024 $1.3B Completed Generating Revenue
3. Early Stage VC 07-Oct-2021 Completed Generating Revenue
2. Seed Round 11-Jul-2020 $3M $3M Completed Generating Revenue
1. University Spin-Out Completed Startup
To view Nerio Therapeutics’s complete valuation and funding history, request access »

Nerio Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Nerio Therapeutics’s complete cap table history, request access »

Nerio Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company intended to empower phosphatase drug discovery for immunotherapy. The company of
Drug Discovery
La Jolla, CA

Natick, MA
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nerio Therapeutics Competitors (76)

One of Nerio Therapeutics’s 76 competitors is PIC Therapeutics, a Venture Capital-Backed company based in Natick, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PIC Therapeutics Venture Capital-Backed Natick, MA
Atavistik Bio Venture Capital-Backed Cambridge, MA
Orionis Biosciences Venture Capital-Backed Waltham, MA
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
Ambrx Formerly PE-Backed San Diego, CA
You’re viewing 5 of 76 competitors. Get the full list »

Nerio Therapeutics Patents

Nerio Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4754097-A2 Protein tyrosine phosphatase degraders and uses thereof Pending 02-Aug-2023
WO-2025030006-A2 Protein tyrosine phosphatase degraders and uses thereof Inactive 02-Aug-2023
WO-2025030006-A3 Protein tyrosine phosphatase degraders and uses thereof Inactive 02-Aug-2023
EP-4753705-A1 Protein tyrosine phosphatase inhibitor combinations Pending 02-Aug-2023
WO-2025030008-A1 Protein tyrosine phosphatase inhibitor combinations Inactive 02-Aug-2023 C07K16/2818
To view Nerio Therapeutics’s complete patent history, request access »

Nerio Therapeutics Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alexandria Venture Investments Venture Capital Minority
Avalon Ventures Venture Capital Minority
Bregua Corporation Venture Capital Minority
Correlation Ventures Venture Capital Minority
University of California, San Diego University
You’re viewing 5 of 6 investors. Get the full list »

Nerio Therapeutics FAQs

  • When was Nerio Therapeutics founded?

    Nerio Therapeutics was founded in 2019.

  • Where is Nerio Therapeutics headquartered?

    Nerio Therapeutics is headquartered in La Jolla, CA.

  • What industry is Nerio Therapeutics in?

    Nerio Therapeutics’s primary industry is Drug Discovery.

  • Is Nerio Therapeutics a private or public company?

    Nerio Therapeutics is a Private company.

  • What is the current valuation of Nerio Therapeutics?

    The current valuation of Nerio Therapeutics is .

  • What is Nerio Therapeutics’s current revenue?

    The current revenue for Nerio Therapeutics is .

  • How much funding has Nerio Therapeutics raised over time?

    Nerio Therapeutics has raised $6.5M.

  • Who are Nerio Therapeutics’s investors?

    Alexandria Venture Investments, Avalon Ventures, Bregua Corporation, Correlation Ventures, and University of California, San Diego are 5 of 6 investors who have invested in Nerio Therapeutics.

  • Who are Nerio Therapeutics’s competitors?

    PIC Therapeutics, Atavistik Bio, Orionis Biosciences, Adaptimmune Therapeutics, and Ambrx are some of the 76 competitors of Nerio Therapeutics.

  • When was Nerio Therapeutics acquired?

    Nerio Therapeutics was acquired on 29-Jul-2024.

  • Who acquired Nerio Therapeutics?

    Nerio Therapeutics was acquired by Boehringer Ingelheim.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process